“The French government does not enjoy a parliamentary majority, it has lost control of parliament”

Date:

Pellistrandi has assured that “everything depends” on the political decision of the French government, that is to classify as radical and benefit from the social movements protesting against the reform, or to insist that the law is created and launch future messages and dialogue.

French historian and political scientist Benoit Pellistrandi assured tonight on Radio Euskadi’s Ganbara that the French government has “lost control of parliament” and that all political parties will try to take advantage of this weak situation. “The extremists have the wind in their favor, they are going to take advantage of the anger of the people,” he explained.

In addition, he has said that now “everything depends” on the political decision taken by the French government, that is to say, to define as radical and benefit from the social movements protesting against the reform, or to insist that the law is made and messages for the future and launch dialogue.

According to Pellistrandi, President Macron is rumored to be able to make statements tomorrow and has assured that he is in a “really difficult” situation as he has to explain to the French that despite not having a majority in parliament, the pension reform has emerged.

(function(d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id)) return;
js = d.createElement(s); js.id = id;
js.src = “//connect.facebook.net/es_ES/sdk.js#xfbml=1&version=v2.8”;
fjs.parentNode.insertBefore(js, fjs);
}(document, ‘script’, ‘facebook-jssdk’));

Source: EITB

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

Meeting with Salvini – “Duce” granddaughter joins Right Lega in Italy

The Dictator character Alessandra Mussolini has left the judge...

24 days all by yourself – Missing survived 13 snowstorms in the mountains

A 27-year-old woman from Georgia, who was missing in...

38 medicines came on the European market in 2024

In the previous year, 38 medicines with new active...